Johnson and Johnson Heartline Study Offering Apple Watch for Senior Participation

Approximately six million people in the United States live with an irregular heart rhythm known as atrial fibrillation (AFib). Up to 30% of those people don’t even know they have it until a serious cardiovascular event, such as stroke, occurs because AFib is often not associated with any symptoms. 

In an effort to change this, Johnson & Johnson, in collaboration with Apple, is offering eligible U.S. adults 65 years and older with an iPhone the opportunity to join the Heartline™ Study, a nationwide heart health research study. 

From our partner

Diagnosed with Advanced Small Cell Lung Cancer? Learn more about a new study for patients with ES-SCLC.

The Heartline™ Study is designed to explore if the Heartline Study app on iPhone and heart health features on Apple Watch can potentially improve heart health outcomes, including reducing the risk of stroke, with earlier detection of AFib.

Each week, participants will have access to a heart health engagement program via the Heartline Study app on iPhone, including wellness tips, surveys and questionnaires across multiple topics related to heart health.

This study is virtual. This means it’s easy to participate from anywhere through your iPhone — including from the comfort of your home — without having to go to a doctor’s office. If you’re 65 or older and interested in being a part of the study, visit Heartline.com to learn more and download the app to see if you’re eligible to enroll.*

From our partner

Having difficulty controlling your hypertension? This clinical trial may help! Learn More Here

^{*Key eligibility criteria include: you must be 65 or older, a U.S. resident for the duration of the study, able to read/understand English, own an iPhone 6s or later (with iOS 12.2 or later) and have Original (Traditional) Medicare. Other eligibility participation requirements will apply.}